Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer

Area of Science:

• Oncology
• Bioinformatics
• Molecular Biology

Background:

• Gastric cancer is a prevalent malignancy with significant global incidence.
• MicroRNAs (miRNAs) are crucial regulators of biological processes, implicated in cancer initiation and progression.
• Identifying therapeutic targets for gastric cancer, particularly those involving dysregulated miRNAs, is a critical research area.

Purpose of the Study:

• To identify over-expressed microRNAs (miRNAs) involved in gastric cancer genesis using bioinformatics.
• To discover specific small molecule inhibitors for these over-expressed miRNAs to potentially arrest oncogenesis.
• To analyze the role of miRNA target genes in cancer-related pathways.

Main Methods:

• Utilized three datasets from the Gene Expression Omnibus (GEO) database to identify differentially expressed miRNAs.
• Performed Gene Ontology and pathway enrichment analysis on experimentally validated miRNA target genes.
• Conducted computer-aided high-throughput virtual screening using Glide to identify small molecule inhibitors for over-expressed miRNAs.

Main Results:

• Identified differentially expressed miRNAs across three independent gastric cancer datasets.
• Confirmed that target genes of these miRNAs are linked to major cancer-associated pathways.
• Successfully identified top five potent small molecule ligands for each over-expressed miRNA based on docking scores.

Conclusions:

• Bioinformatics approaches can effectively identify key miRNAs and their targets in gastric cancer.
• The identified small molecules show potential as specific inhibitors for over-expressed miRNAs in gastric cancer.
• This study provides a foundation for developing novel targeted therapies against gastric cancer by modulating miRNA activity.